Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARCOVAC: Seasonal Influenza Vaccine in Sarcoidosis
NCT01687517Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2012
- Primary completion
- Jun 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ARCT-2138 in influenza, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2012; status: completed.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01687517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687517.